UPSC CURRENT AFFAIRS | INDIA’S mRNA COVID VACCINE | 30TH JUNE | INDIAN EXPRESS
SYLLABUS SECTION: WHY IN THE NEWS? Recently, the country’s first homegrown INDIA’S mRNA Covid-19 vaccine, GEMCOVAC-19, developed at Pune’s Gennova Biopharmaceuticals, has got ‘restricts emergency use’ approval for the 18-and-above age group. How mRNA vaccines work? Most traditional vaccines put a weakened or inactivated virus in the body to generate an immune response. An mRNA …
UPSC CURRENT AFFAIRS | INDIA’S mRNA COVID VACCINE | 30TH JUNE | INDIAN EXPRESS Read More »